Alphina Therapeutics, Inc.

CIK 1882991 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alphina Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 16, 2026D0001882991-26-000003
Sep 15, 2021D0001882991-21-000001